GlassScriptPhysician profile
Cornell Shelton
NPI 1003807538
$3,568.71
in general payments reported to CMS, 2019-2025
28 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,238 · 2020: $353 · 2021: $422 · 2022: $484 · 2023: $523 · 2024: $342 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,013.97 | 2019-2025 | Collagenase Santyl, Regranex, Grafix |
| Keswick Pharmaceuticals LLC | $624.45 | 2019 | |
| Organogenesis INC. | $513.29 | 2019-2024 | Puraply |
| Abbvie INC. | $265.19 | 2021-2024 | Dalvance |
| Hydrofera LLC | $130.48 | 2023-2024 | Hydrofera Blue, Hydrofera Blue Ready - Border |
| Solventum Corporation | $122.79 | 2024-2025 | Activ.A.C., 3m Cavilon, 3m Coban |
| Paratek Pharmaceuticals, INC. | $109.20 | 2019-2023 | Nuzyra |
| Convatec INC. | $99.51 | 2019-2024 | |
| Kci USA, INC. | $84.57 | 2020-2023 | Promogran Prisma, Activ.A.C. |
| Misonix INC | $62.39 | 2019-2021 | |
| Kerecis Limited | $60.27 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osiris Therapeutics INC. | $45.88 | 2019 | |
| Ovik Health, LLC | $44.64 | 2021 | |
| Reapplix INC. | $44.52 | 2023 | 3c Patch Kit - Box |
| Mimedx Group, INC. | $40.15 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $38.61 | 2023 | Blastx, Xperience, Surgx |
| Melinta Therapeutics, LLC | $35.78 | 2019 | |
| Aroa Biosurgery Incorporated | $35.28 | 2023 | |
| Bioventus LLC | $26.24 | 2022 | |
| Molnlycke Health Care US, LLC | $24.94 | 2025 | Mepilex Border Flex, Mesalt, Exufiber |
| Bsn Medical INC | $23.27 | 2022 | |
| Nabriva Therapeutics, Plc | $23.01 | 2022 | |
| Linvatec Corporation | $18.30 | 2020 | |
| Reprise Biomedical, INC. | $18.03 | 2025 | Miro3d |
| Omeza LLC | $17.49 | 2023 | |
| Cashflow Solutions, LLC | $16.52 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Medela LLC | $15.84 | 2020 | |
| Integra Lifesciences Corporation | $14.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornell Shelton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.